A phase I/II trial of concurrent immunotherapy with chemoradiation in locally advanced larynx cancer

OBJECTIVES: Cisplatin‐based chemoradiation is an established organ‐preserving strategy for locally advanced laryngeal cancer, but long‐term survival remains suboptimal. Immunotherapy has been studied in the metastatic and unresectable recurrent settings. However, additional data are needed to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Frankart, Andrew J., Sadraei, Nooshin Hashemi, Huth, Brad, Redmond, Kevin P., Barrett, William L., Kurtzweil, Nicky, Riaz, Muhammad K., Wise‐Draper, Trisha, Rodriguez, Cristina P., Adelstein, David J., Takiar, Vinita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Head and Neck, and Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008154/
https://www.ncbi.nlm.nih.gov/pubmed/35434343
http://dx.doi.org/10.1002/lio2.780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008154/
https://www.ncbi.nlm.nih.gov/pubmed/35434343
http://dx.doi.org/10.1002/lio2.780

Ejemplares similares